Monohydroxyeicosatetraenoic acids (5-HETE and 15-HETE) induce pulmonary vasoconstriction and edema.
- 1 April 1988
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 62 (4) , 687-698
- https://doi.org/10.1161/01.res.62.4.687
Abstract
5-, 15-, and 12-HETE (monohydroxyeicosatetraenoic acids) are products of the lipoxygenation of arachidonic acid. We investigated their role as possible mediators of pulmonary vasoactivity and pulmonary edema. Pulmonary artery pressure (Ppa), capillary pressure (Pcap), the change in lung wet weight (delta wt) from baseline, and capillary filtration coefficient (Kf) (as a measure of vascular permeability) were determined following an intravenous injection of each mono-HETE in lungs perfused at constant flow with either a phosphate-buffered Ringer's-albumin solution (PBR) or diluted blood. Injection of 2 micrograms of each compound into the pulmonary artery of lungs perfused with either PBR or diluted blood did not produce any effect. However, in PBR-perfused lungs, 4 micrograms 15-HETE induced increases in Ppa, Pcap, and lung wet weight (p less than 0.05), which were greater than the increases observed after 4 micrograms 5-HETE. Kf increased following both 5- and 15-HETE. The pulmonary vasoconstrictor and edemagenic responses were attenuated by increasing perfusate albumin concentration from 0.5 to 1.5 g%. In contrast, 12-HETE (4 micrograms) had no effect on these parameters. In blood-perfused lungs, the pulmonary vascular responses to all HETE compounds (4 micrograms) were attenuated. In both Ringer's-albumin-perfused and blood-perfused lungs, the relative magnitude of the hemodynamic and fluid filtration responses to each mono-HETE were as follows: 15-HETE greater than 5-HETE greater than 12-HETE. In conclusion, the pulmonary vasoconstrictor and edemagenic effects of 5- and 15-HETE occur independently of blood-formed elements. 15-HETE causes greater pulmonary vasoconstriction and edema than 5-HETE. Both 5- and 15-HETE induce pulmonary edema, probably as a result of increased lung vascular permeability. The results indicate that 5- and 15-HETE are potent pulmonary inflammatory mediators.This publication has 27 references indexed in Scilit:
- Influence of Steroidal and Nonsteroidal Anti-Inflammatory Agents on the Accumulation of Arachidonic Acid Metabolites in Plasma and Lung Lymph after Endotoxemia in Awake SheepAmerican Review of Respiratory Disease, 1986
- Neutrophil degranulation: Evidence pertaining to its mediation by the combined effects of leukotriene B4, platelet‐activating factor, and 5‐HETEJournal of Cellular Physiology, 1985
- Regulation of leukocyte and platelet lipoxygenases by hydroxyeicosanoidsBiochemical Pharmacology, 1982
- Stimulation of leukotriene biosynthesis in human blood leukocytes by platelet-derived 12-hydroperoxy-icosatetraenoic acid.Proceedings of the National Academy of Sciences, 1982
- Uptake and metabolism of monohydroxy-eicosatetraenoic acids by macrophages.The Journal of Experimental Medicine, 1982
- Selective feed-back inhibition of the 5-lipoxygenation of arachidonic acid in human T-lymphocytesBiochemical and Biophysical Research Communications, 1981
- Metabolism of arachidonic acid in ionophore-stimulated neutrophils. Esterification of a hydroxylated metabolite into phospholipids.Journal of Clinical Investigation, 1979
- 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid, a chemotactic fatty acid, is incorporated into neutrophil phospholipids and triglycerideProstaglandins, 1979
- Arachidonic acid metabolism in polymorphonuclear leukocytes: unstable intermediate in formation of dihydroxy acids.Proceedings of the National Academy of Sciences, 1979
- Arachidonic acid metabolism in polymorphonuclear leukocytesProceedings of the National Academy of Sciences, 1979